Synthesis and biological evaluation of capsaicin analogues as antioxidant and neuroprotective agents
Capsaicin and its analogues 3a-3q were designed and synthesized as potential new antioxidant and neuroprotective agents. Many analogues exhibited good antioxidant effects, and some showed more potent free radical scavenging activities than the positive drug quercetin (IC 50 = 8.70 ± 1.75 μM for DPPH...
Saved in:
Published in | RSC advances Vol. 13; no. 46; pp. 3215 - 32159 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge
Royal Society of Chemistry
01.11.2023
The Royal Society of Chemistry |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Capsaicin and its analogues
3a-3q
were designed and synthesized as potential new antioxidant and neuroprotective agents. Many analogues exhibited good antioxidant effects, and some showed more potent free radical scavenging activities than the positive drug quercetin (IC
50
= 8.70 ± 1.75 μM for DPPH assay and 13.85 ± 2.87 μM for ABTS assay, respectively). The phenolic hydroxyl of capsaicin analogues was critical in determining antioxidant activity. Among these compounds,
3k
displayed the most potent antioxidant activity. Cell vitality tests revealed that the representative compound
3k
was good at protecting cells from H
2
O
2
-induced oxidative damage at low concentrations (cell viability increased to 90.0 ± 5.5% at 10 μM). In addition, the study demonstrated that
3k
could reduce intracellular ROS accumulation and increase GSH levels to prevent H
2
O
2
-induced oxidative stress in SY5Y cells. In the mitochondrial membrane potential assay,
3k
significantly increased the MMP level of SY5Y cells treated with H
2
O
2
and played an anti-neuronal cell death role. These results provide a promising strategy to develop novel capsaicin analogues as potential antioxidant and neuroprotective agents.
We designed and synthesized a novel series of capsaicin analogues, and explored their utility for antioxidant and neuroprotective agents. |
---|---|
Bibliography: | Electronic supplementary information (ESI) available: Experimental procedures including characterization data of novel synthetic compounds. See DOI https://doi.org/10.1039/d3ra05107b ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. |
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/d3ra05107b |